Patent Assignment
Reel/Frame 054641/0399
Assignment of Assignor's Interest
Recorded: 2020-12-14
Pages: 21
Assignor
LEADIANT BIOSCIENCES LIMITED
Executed: 2020-10-09
Assignee
UNIKERIS LIMITED
21 HOLBORN VIADUCT, LONDON, EC1A 2DY, UNITED KINGDOM
Covered Properties
(2)
Adenosine Deaminase Anticancer Therapy
Stable Recombinant Adenosine Deaminase
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 13, 2008
From: FILPULA, DAVID R; SAPRA, PUJA
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 021093/0804 →
Assignment of Assignor's Interest
Jun 16, 2008
From: FILPULA, DAVID R.; YOUNGSTER, STEPHEN K.
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 021099/0336 →
Assignment of Assignor's Interest
Feb 16, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 023937/0530 →
Corrective Assignment to Correct the Applicant's Address Must Be Corrected in the Electronic Patent Assignment System Previously Recorded on Reel 023937 Frame 0533. Assignor(S) Hereby Confirms the Correct Address Is Rua Dos Ferreiros 260, Funchal-Madeira, Portugal, 9000-082.
Apr 26, 2010
From: ENZON PHARMACEUTICALS, INC.
To: DEFIANTE FARMACEUTICA, S.A.
Reel/Frame 024286/0076 →
Assignment of Assignor's Interest
Feb 7, 2012
From: DEFIANTE FARMACEUTICA, S.A.
To: SIGMA-TAU RARE DISEASES, S.A.
Reel/Frame 027662/0812 →
Merger
Apr 29, 2015
From: SIGMA TAU RARE DISEASES S.A.
To: SIGMA-TAU PHARMA LIMITED
Reel/Frame 035551/0219 →
Assignment of Assignor's Interest
Jul 1, 2015
From: SIGMA-TAU PHARMA LIMITED
To: SIGMA-TAU RARE DISEASE LTD
Reel/Frame 035948/0139 →
Change of Name
Dec 12, 2016
From: SIGMA-TAU RARE DISEASE LIMITED
To: LEADIANT BIOSCIENCES LIMITED
Reel/Frame 040716/0853 →
Change of Address
Mar 17, 2021
From: UNIKERIS LIMITED
To: UNIKERIS LIMITED
Reel/Frame 055616/0640 →